Skinbiotherapeutics – just wondering about those interims?
Last year, Skinbiotherapeutics (SBTX) announced on 8 March that its interim results, to December 31, would be out on 22 March and they duly arrived on that day. To be fair to the bearded Geordie poltroon, Stuart Ashman, he has historically been jolly good about issuing an RNS to flag up when results will be out and past performance is, whatever the FCA says, very often a good guide to the future. But…


